Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-31 to 2024-06-10
Current total value of award: $79.33
Description: 8510669434!MIDAZOLAM HYDROCHLO